Figure 2From: Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritisComparison of adverse event rates with mycophenolate mofetil in systemic lupus erythematosus in a pooled analysis of randomised controlled trials (RCT) and observational studies reporting on patients with lupus nephritis. GI, gastrointestinal adverse events.Back to article page